Amgen ‘very encouraged’ by preliminary data from weight-loss drug trial, stock jumps

im 814193
Shares of Amgen Inc. rallied in the extended session Thursday after the drugmaker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.

Source link

About The Author

Scroll to Top